Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

Investors choose to redeem or convert the majority of Series C and Series D Preferred

99% of outstanding preferred series C shares are redeemed or converted and preferred series D reduced 68.5% in outstanding shares

Read more at globenewswire.com